Precipio, Inc.
PRPONasdaq
$24.64
↑ +4.1%Jul 17 close · end-of-day
Price
1Y↑ +68.4%
End-of-day closes; the latest point is the live 15-min-delayed price · split & dividend adjusted · chart by TradingView
Key statistics
Market Cap
$43.9M
Enterprise Value
$41.4M
P/E
—
P/S
1.7
P/B
3.1
EV/EBITDA
—
PEG
—
FCF Yield
1.3%
Dividend Yield
—
Revenue (TTM)
$25.8M
Net Income (TTM)
—
Free Cash Flow (TTM)
$555,000.00
Gross Margin
43.7%
Operating Margin
-6.9%
Net Margin
—
ROE
—
ROIC
-12.0%
Debt / Equity
0.0
Net Cash
$2.5M
Return 1Y
+73.6%
Company profile
Precipio, Inc. provides diagnostic blood cancer testing services in the United States. The company sells ICE-COLD-PCR technology kits to bio-pharma customers. It has collaborations with academic institutions specializing in cancer research, diagnostics, and treatment.
- CEO
- Ilan Danieli
- Sector
- Manufacturing
- Industry
- Measuring And Control Equipment
- Employees
- 60
- Headquarters
- Connecticut
- Website
- precipiodx.com
Earnings
PRPO Q1 2026 Earnings
Period ends 2026-03-31
MetricActualYoY
Revenue$6.7M↑ +36.2%
Diluted EPS-$0.81↑ +37.3%
Actuals from SEC filings; YoY vs the year-ago quarter. Analyst estimates & surprise require a data feed (coming soon).
Financial statements
| Line item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Revenue | $6.1M | $8.8M | $9.4M | $15.2M | $18.5M | $24.0M |
| Gross profit | $1.1M | $2.4M | $2.5M | $6.0M | $7.6M | $10.7M |
| Operating income | -$9.1M | -$9.6M | -$12.8M | -$7.6M | -$4.2M | -$1.2M |
| Net income | — | — | — | -$5.9M | -$4.3M | -$363,000.00 |
| Diluted EPS | -$0.85 | -$0.40 | -$10.73 | -$4.51 | -$2.93 | -$0.23 |
| Operating cash flow | -$7.4M | -$6.6M | -$7.7M | -$3.6M | $439,000.00 | $685,000.00 |
| Free cash flow | -$7.6M | -$7.3M | -$8.0M | -$3.7M | $216,000.00 | $359,000.00 |
| Gross margin | 18.9% | 27.0% | 26.7% | 39.6% | 40.8% | 44.5% |
| Operating margin | -150.1% | -108.6% | -136.0% | -50.1% | -22.7% | -5.0% |
| Net margin | — | — | — | -38.5% | -23.1% | -1.5% |
| Line item | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $4.4M | $5.2M | $5.5M | $4.9M | $5.7M | $6.8M | $6.7M | $6.7M |
| Gross profit | $1.7M | $2.3M | $2.6M | $2.1M | $2.4M | $3.0M | $3.1M | $2.7M |
| Operating income | -$1.2M | -$597,000.00 | -$336,000.00 | -$859,000.00 | -$824,000.00 | -$61,000.00 | $542,000.00 | -$1.4M |
| Net income | — | — | — | -$884,000.00 | — | — | — | -$1.4M |
| Diluted EPS | -$0.83 | -$0.42 | -$0.22 | -$0.59 | $0.05 | -$0.05 | $0.36 | -$0.81 |
| Operating cash flow | $500,000.00 | $41,000.00 | $565,000.00 | -$44,000.00 | $353,000.00 | $10,000.00 | $366,000.00 | $64,000.00 |
| Free cash flow | — | -$68,000.00 | — | -$182,000.00 | $294,000.00 | -$44,000.00 | $291,000.00 | $14,000.00 |
| Gross margin | 38.6% | 43.7% | 48.6% | 43.4% | 43.0% | 44.4% | 46.8% | 40.6% |
| Operating margin | -27.2% | -11.5% | -6.2% | -17.4% | -14.6% | -0.9% | 8.1% | -21.3% |
| Net margin | — | — | — | -17.9% | — | — | — | -21.5% |
Company news
Analyst estimates
Coming soonConsensus revenue & EPS estimates and price targets will appear here once a forward-estimates data feed is connected.
Insider transactions
BoughtSoldMonthly insider $ volume · trailing 12 months
| Date | Insider | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| 2026-07-15 | Cohen David Seth | Award | 520 | $25.24 | $13,124.80 | filing |
| 2026-07-15 | Cossman Jeffrey | Award | 416 | $25.24 | $10,499.84 | filing |
| 2026-07-15 | Valauri Christina Rizopoulos | Award | 108 | $25.24 | $2,725.92 | filing |
| 2026-05-21 | SANDBERG RICHARD A | Sale | 900 | $25.02 | $22,517.37 | filing |
| 2026-05-20 | SANDBERG RICHARD A | Sale | 2,034 | $24.89 | $50,631.96 | filing |
| 2026-05-20 | SANDBERG RICHARD A | Sale | 500 | $25.00 | $12,500.00 | filing |
| 2026-05-19 | SANDBERG RICHARD A | Sale | 600 | $24.42 | $14,652.36 | filing |
| 2026-04-15 | Cohen David Seth | Award | 445 | $29.49 | $13,123.05 | filing |
| 2026-04-15 | Cossman Jeffrey | Award | 365 | $29.49 | $10,763.85 | filing |
| 2026-04-15 | Valauri Christina Rizopoulos | Award | 93 | $29.49 | $2,742.57 | filing |
| 2026-04-01 | Sabet Ahmed Zaki· Chief Operating Officer | Buy | 19 | $27.93 | $530.67 | filing |
| 2026-01-15 | Cohen David Seth | Award | 546 | $24.00 | $13,104.00 | filing |
| 2026-01-15 | LAPORTE KATHLEEN | Award | 520 | $24.00 | $12,480.00 | filing |
| 2026-01-15 | Cossman Jeffrey | Award | 437 | $24.00 | $10,488.00 | filing |
| 2026-01-15 | Valauri Christina Rizopoulos | Award | 406 | $24.00 | $9,744.00 | filing |
| 2026-01-02 | Sabet Ahmed Zaki· Chief Operating Officer | Buy | 20 | $23.40 | $468.00 | filing |
| 2026-01-02 | Sabet Ahmed Zaki· Chief Operating Officer | Buy | 20 | $23.40 | $468.00 | filing |
| 2025-10-15 | Cohen David Seth | Award | 746 | $17.58 | $13,114.68 | filing |
| 2025-10-15 | Cohen David Seth | Award | 746 | $17.58 | $13,114.68 | filing |
| 2025-10-15 | LAPORTE KATHLEEN | Award | 711 | $17.58 | $12,499.38 | filing |
| 2025-10-15 | Cossman Jeffrey | Award | 597 | $17.58 | $10,495.26 | filing |
| 2025-10-15 | Cossman Jeffrey | Award | 597 | $17.58 | $10,495.26 | filing |
| 2025-10-15 | ANDREWS RONALD ASBURY | Award | 568 | $17.58 | $9,985.44 | filing |
| 2025-10-15 | ANDREWS RONALD ASBURY | Award | 568 | $17.58 | $9,985.44 | filing |
| 2025-10-01 | Sabet Ahmed Zaki· Chief Operating Officer | Buy | 25 | $19.50 | $487.50 | filing |
Showing the latest 25 transactions — full history in the linked SEC filings.
Fundamentals & filings from SEC EDGAR. Prices adjusted for splits & dividends. Not investment advice.